Bank of New York Mellon Corp Takes Position in Sotera Health Company $SHC

Key Points

• Bank of New York Mellon purchased 1.54 million Sotera Health shares worth approximately $27.4 million, gaining a 0.54% stake. Institutional investors collectively own 91.03% of SHC.
• Analysts maintain a generally positive outlook, with eight Buy ratings and three Holds. Sotera Health has an average “Moderate Buy” rating and a consensus price target of $21.50.
• Sotera Health exceeded quarterly expectations with EPS of $0.26 versus $0.24 expected and revenue of $321.4 million, up 9.2% year over year. However, insiders sold roughly 1.29 million shares worth $24.0 million over the past three months.

Bank of New York Mellon Corp purchased a new position in Sotera Health Company (NASDAQ:SHC - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,544,672 shares of the company's stock, valued at approximately $27,418,000. Bank of New York Mellon Corp owned 0.54% of Sotera Health as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. Focus Partners Advisor Solutions LLC purchased a new position in shares of Sotera Health during the 2nd quarter valued at about $401,000. State of Wyoming purchased a new stake in Sotera Health during the second quarter valued at about $1,006,000. Handelsbanken Fonder AB grew its stake in shares of Sotera Health by 26.8% during the second quarter. Handelsbanken Fonder AB now owns 90,300 shares of the company's stock valued at $1,603,000 after buying an additional 19,100 shares during the last quarter. GAMMA Investing LLC boosted its position in Sotera Health by 58.9% during the 2nd quarter. GAMMA Investing LLC now owns 9,361 shares of the company's stock valued at $166,000 after buying an additional 3,471 shares during the period. Finally, Pacer Advisors Inc. raised its holdings in shares of Sotera Health by 12.4% during the first quarter. Pacer Advisors Inc. now owns 36,161 shares of the company's stock valued at $519,000 after acquiring an additional 3,988 shares in the last quarter. 91.03% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on SHC. Weiss Ratings raised shares of Sotera Health from a "hold (c)" rating to a "hold (c+)" rating in a research note on Tuesday, August 11th. The Goldman Sachs Group began coverage on Sotera Health in a report on Friday, June 5th. They issued a "buy" rating and a $20.00 target price on the stock. Piper Sandler reissued an "overweight" rating and issued a $25.00 target price (up from $22.00) on shares of Sotera Health in a research note on Friday, August 7th. JPMorgan Chase & Co. upped their target price on shares of Sotera Health from $16.00 to $18.00 and gave the stock a "neutral" rating in a research note on Friday, August 7th. Finally, UBS Group set a $19.00 price target on shares of Sotera Health in a report on Wednesday, June 24th. Eight equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat, Sotera Health currently has an average rating of "Moderate Buy" and an average target price of $21.50.

Insider Transactions at Sotera Health

In other Sotera Health news, Chairman Michael B. Jr. Petras sold 850,000 shares of Sotera Health stock in a transaction on Monday, August 17th. The shares were sold at an average price of $18.50, for a total value of $15,725,000.00. Following the sale, the chairman directly owned 3,969,393 shares in the company, valued at approximately $73,433,770.50. The trade was a 17.64% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Michael P. Rutz sold 150,000 shares of Sotera Health stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $18.84, for a total value of $2,826,000.00. Following the completion of the sale, the insider directly owned 334,279 shares in the company, valued at $6,297,816.36. This trade represents a 30.97% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 1,294,515 shares of company stock worth $23,999,528. Insiders own 15.36% of the company's stock.

Sotera Health Stock Performance

SHC stock opened at $19.27 on Friday. Sotera Health Company has a 1 year low of $13.09 and a 1 year high of $19.85. The stock's fifty day moving average price is $18.12 and its 200-day moving average price is $16.41. The company has a debt-to-equity ratio of 3.33, a current ratio of 2.80 and a quick ratio of 2.55. The company has a market cap of $5.50 billion, a P/E ratio of 33.81 and a beta of 1.77.

Sotera Health (NASDAQ:SHC - Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.02. The company had revenue of $321.38 million during the quarter, compared to analyst estimates of $309.70 million. Sotera Health had a net margin of 13.44% and a return on equity of 40.12%. The firm's quarterly revenue was up 9.2% compared to the same quarter last year. During the same period in the previous year, the business posted $0.20 earnings per share. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. On average, equities analysts forecast that Sotera Health Company will post 0.86 earnings per share for the current year.

Sotera Health Company Profile

Sotera Health Inc NASDAQ: SHC is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.

Want to see what other hedge funds are holding SHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sotera Health Company (NASDAQ:SHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source